Cigna Group (CI) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Cigna’s revenue went from $39.8B in fiscal 2016 to $274.9B in fiscal 2025, growth of about 23.9% a year.
Net income in fiscal 2025 was $6.0B, a net margin of 2.2%; the best year in this period was 2020 with $8.5B.
Over the twelve months to September 30, 2026, revenue was $286.3B and net income $6.0B.
The diluted share count rose 3% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $286.3B | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B | $160.4B | $153.6B | $48.6B | $41.8B | $39.8B |
| Gross profit | $59.1B | $59.9B | $64.6B | $61.5B | $55.7B | $56.5B | $56.9B | $55.9B | $43.9B | $39.4B | $37.4B |
| Operating income | $9.8B | $9.2B | $9.4B | $8.5B | $8.4B | $7.9B | $8.2B | $8.1B | $4.2B | $3.9B | $3.1B |
| Net income | $6.0B | $6.0B | $3.4B | $5.2B | $6.7B | $5.4B | $8.5B | $5.1B | $2.6B | $2.2B | $1.9B |
| EPS (diluted) | $22.68 | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +11.2% | +26.6% | +8.2% | +3.7% | +8.5% | +4.5% | +215.6% | +16.4% | +4.9% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.4B | $9.6B | $10.4B | $11.8B | $8.7B | $7.2B | $10.3B | $9.5B | $3.8B | $4.1B | $4.0B |
| Capital spending | -$1.2B | — | — | — | — | — | — | -$1.1B | -$528M | -$471M | -$461M |
| Free cash flow | $8.3B | — | — | — | — | — | — | $8.4B | $3.2B | $3.6B | $3.6B |
| Dividends paid | $1.6B | $1.6B | $1.6B | $1.4B | $1.4B | $1.3B | $15M | $15M | $10M | $10M | $10M |
| Buybacks | $1.5B | $3.6B | $7.0B | $2.3B | $7.6B | $7.7B | $4.0B | $2.0B | $342M | $2.7B | $139M |
| Stock-based pay | — | $291M | $308M | $286M | $264M | $268M | $289M | $299M | $180M | $178M | $128M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $8.7B | $8.2B | $8.7B | $6.8B | $6.0B | $11.5B | $5.6B | $5.9B | $5.1B | $3.2B |
| Debt | — | $31.5B | $32.0B | $31.4B | $31.6B | $33.7B | $33.6B | $38.0B | $39.5B | $5.3B | — |
| Equity | — | $41.7B | $41.0B | $46.2B | $44.7B | $47.1B | $50.3B | $45.3B | $41.0B | $13.7B | $13.7B |
| Total assets | — | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B | $155.5B | $155.8B | $153.2B | $61.8B | — |
| Shares (diluted) | 264M | 269M | 283M | 297M | 313M | 341M | 368M | 380M | 250M | 255M | 260M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 20.7% | 21.8% | 26.2% | 31.5% | 30.9% | 32.5% | 35.5% | 36.4% | 90.1% | 94.1% | 93.8% |
| Operating margin | 3.4% | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | 9.4% | 7.8% |
| Net margin | 2.1% | 2.2% | 1.4% | 2.6% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | 5.3% | 4.7% |
| FCF margin | 2.9% | — | — | — | — | — | — | 5.5% | 6.7% | 8.6% | 8.9% |
| ROIC | — | 10.2% | 9.2% | 10.7% | 8.9% | 7.8% | 7.6% | 7.5% | 3.8% | 12.8% | 13.9% |
| ROE | — | 14.3% | 8.4% | 11.2% | 15.0% | 11.4% | 16.8% | 11.3% | 6.4% | 16.3% | 13.6% |
Frequently asked questions
What is Cigna’s annual revenue?
$274.9B in fiscal 2025 and $286.3B over the twelve months to September 30, 2026.
How much profit does Cigna make?
Net income was $6.0B in fiscal 2025 (net margin 2.2%).
Is Cigna’s revenue growing?
Yes: revenue rose 11.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.